Fat emulsion for oral administration
    1.
    发明授权
    Fat emulsion for oral administration 有权
    用于口服的脂肪乳剂

    公开(公告)号:US06537561B1

    公开(公告)日:2003-03-25

    申请号:US09367650

    申请日:1999-08-18

    IPC分类号: A61K9127

    摘要: An O/W medical fat emulsion for oral administration, which is capable of increasing the bioavailability of a medicine or the blood level thereof. The emulsion is composed of fat emulsion particles containing an oil component, an emulsifier and a medicine as the indispensable constituents and dispersed in water, characterized in that the average diameter of the particles in the fat emulsion ranges from 5 to 50 nm. A freeze-dried preparation of the emulsion is also included in the invention.

    摘要翻译: 一种用于口服给药的O / W医用脂肪乳剂,其能够增加药物的生物利用度或其血液水平。 该乳液由含有油成分,乳化剂和作为不可缺少成分的药物的脂肪乳液颗粒构成,分散在水中,其特征在于脂肪乳剂中的颗粒的平均直径为5〜50nm。 乳液的冷冻干燥制剂也包括在本发明中。

    Method of producing emulsions and an emulsification apparatus
    3.
    发明授权
    Method of producing emulsions and an emulsification apparatus 失效
    生产乳液的方法和乳化设备

    公开(公告)号:US5843334A

    公开(公告)日:1998-12-01

    申请号:US765486

    申请日:1996-12-13

    摘要: There is provided a method of producing an emulsion by which an emulsion consisting of uniform and microfine globules can be easily obtained with a reduced energy input as compared with the conventional technology. This method of producing an emulsion comprises applying a back pressure equal to not less than 0.2% but less than 5% of the pressure acting on the point of high-pressure emulsifying action in a high-pressure emulsification zone in the course of production of an emulsion with a high-pressure emulsification equipment. The back pressure can be obtained typically by equipping an emulsification machine with a pipeline smaller in inside diameter than the discharge line of the machine.

    摘要翻译: PCT No.PCT / JP95 / 01209 Sec。 371日期1996年12月13日第 102(e)日期1996年12月13日PCT Filed 1995年6月19日PCT公布。 公开号WO95 / 35157 日期为1995年12月28日提供了一种乳液的制造方法,与常规技术相比,能够以较少的能量输入容易地获得由均匀和微细球形成的乳液。 该制造乳液的方法包括在制造过程中施加相当于在高压乳化区域中作用于高压乳化作用点的压力的不小于0.2%但小于5%的背压 用高压乳化设备乳化。 通常通过使乳化机具有比机器的排出管线更小的内径的管道,可以获得背压。

    Dispersion preparation
    4.
    发明授权
    Dispersion preparation 失效
    分散剂

    公开(公告)号:US5776904A

    公开(公告)日:1998-07-07

    申请号:US50217

    申请日:1993-06-03

    CPC分类号: A61K31/7048

    摘要: Liquid dispersions are produced wherein amphotericin B, the methyl ester thereof, nystatin, trichomycin, primaricin and the like having a particle size of 10 .mu.m or less are dispersed in a suitable solvent such as physiologically acceptable saline. The dispersions are particularly useful for parenteral administration.

    摘要翻译: PCT No.PCT / JP91 / 01564 Sec。 371日期:1993年6月3日 102(e)日期1993年6月3日PCT 1991年11月15日PCT PCT。 出版物WO92 / 08467 日期1992年5月29日制造液体分散体,其中将两性霉素B,其甲酯,制霉菌素,霉酚酸等,具有10μm或更小的粒度分散在合适的溶剂如生理学上可接受的盐水中。 分散体对于肠胃外给药特别有用。

    Remedies for hepatitis
    5.
    发明授权
    Remedies for hepatitis 失效
    肝炎救治

    公开(公告)号:US07205282B1

    公开(公告)日:2007-04-17

    申请号:US09646135

    申请日:1999-03-23

    IPC分类号: A61K31/70 A01N43/04

    摘要: The object of the present invention is to provide a novel medicinal agent useful in the treatment or the prevention of hepatitis.The present invention is, for example, a therapeutic or preventive agent for hepatitis characterized in that it comprises a complex of a drug carrier consisting essentially of 2-O-(2-diethylaminoethyl)-carbamoyl-1,3-O-dioleoylglycerol and a phospholipid with poly(I).poly(C).

    摘要翻译: 本发明的目的是提供一种可用于治疗或预防肝炎的新型药剂。

    PGE.sub.1 -containing-freeze dried preparation and process for the
production thereof
    6.
    发明授权
    PGE.sub.1 -containing-freeze dried preparation and process for the production thereof 失效
    含PGE1的冷冻干燥制剂及其制备方法

    公开(公告)号:US5977172A

    公开(公告)日:1999-11-02

    申请号:US43203

    申请日:1998-03-12

    摘要: The object of the invention is to provide a high-quality pharmaceutical preparation in the field of PGE.sub.1 -containing fat emulsions, which is more stable bacteriologically, thermally, and against aging than any preparation hereto fore available.The invention, thus, relates to a PGE.sub.1 -containing lyophilized composition derived from a fat emulsion comprising PGE.sub.1, an oil component, an emulsifier, and water having a pH controlled within the neutral region. Stated differently, the invention relates to a PGE.sub.1 -containing lyophilized composition characterized by comprising PGE.sub.1, an oil component, an emulsifier and designed to give a fat emulsion having a pH within the neutral region upon reconstitution with distilled water of pH 7.0.

    摘要翻译: PCT No.PCT / JP96 / 02611 Sec。 371日期1998年3月12日 102(e)1998年3月12日PCT PCT 1996年9月12日PCT公布。 出版物WO97 / 09986 1997年3月20日本发明的目的是提供一种含PGE1的脂肪乳剂领域的高质量药物制剂,其比任何可用的制剂在细菌,热和抗老化方面更稳定。 因此,本发明涉及由包含PGE1,油组分,乳化剂和pH控制在中性区域内的水的脂肪乳剂得到的含PGE1的冻干组合物。 换句话说,本发明涉及含有PGE1的冻干组合物,其特征在于包含PGE1,油组分,乳化剂,并且被设计成在用pH7.0的蒸馏水重构后得到pH在中性区域内的脂肪乳剂。

    Fat emulsions for inhalational administration
    8.
    发明授权
    Fat emulsions for inhalational administration 失效
    用于吸入给药的脂肪乳剂

    公开(公告)号:US06544542B1

    公开(公告)日:2003-04-08

    申请号:US09623331

    申请日:2000-08-30

    IPC分类号: A61F1300

    摘要: The object of the present invention is to provide a pharmaceutical composition optimized for the administration of a drug, particularly a drug which is only sparingly soluble in water, by way of inhalation. The present invention is a fat emulsion for inhalational administration, or a lyophilized composition thereof, which is an o/w fat emulsion comprising fat emulsion particles essentially composed of an oil component, an emulsifying agent and a drug as dispersed in water, characterized in that the average particle diameter of said fat emulsion particles lies within the range of 5˜100 nm. With the aid of a suitable inhaler, the inhalant of the invention readily yields a mist of aerosol particles fine enough to reach the alveolus; the inhalant is well amenable to size control of the aerosol particles.

    摘要翻译: 本发明的目的是提供一种药物组合物,其优选用于通过吸入给药药物,特别是仅微溶于水的药物。本发明是用于吸入给药的脂肪乳剂或冻干的 其组合物是包含基本上由油组分,乳化剂和分散在水中的药物组成的脂肪乳剂颗粒的o / w脂肪乳剂,其特征在于所述脂肪乳剂颗粒的平均粒径在 5〜100nm。借助合适的吸入器,本发明的吸入剂容易产生足够细小的气雾剂雾气到达肺泡; 吸入剂适合于调整气溶胶颗粒的尺寸。

    Process for producing composite preparation containing nucleic acid
    9.
    发明授权
    Process for producing composite preparation containing nucleic acid 失效
    制备含有核酸的复合制剂的方法

    公开(公告)号:US06746690B2

    公开(公告)日:2004-06-08

    申请号:US10294865

    申请日:2002-11-14

    IPC分类号: A61K9127

    摘要: A method for producing a composition including a nucleic-acid-containing complex is characterized in that two single strand nucleic acid polymers which can at least partly form double strands are separately mixed, in a single strand form, with a cationic carrier or with source materials for the cationic carrier before the cationic carrier is formed. The resulting mixture is then dispersed in water during the production process of the nucleic-acid-containing complex.

    摘要翻译: 制备包含含核酸复合物的组合物的方法的特征在于,可以至少部分形成双链的两条单链核酸聚合物以单链形式与阳离子载体或源材料分开混合 在阳离子载体形成之前为阳离子载体。 然后将所得混合物在含核酸复合物的制备过程中分散在水中。

    Process for producing composite preparation containing nucleic acid
    10.
    发明授权
    Process for producing composite preparation containing nucleic acid 失效
    制备含有核酸的复合制剂的方法

    公开(公告)号:US06545138B1

    公开(公告)日:2003-04-08

    申请号:US09701072

    申请日:2000-11-20

    IPC分类号: C07H2104

    摘要: A method for producing a composition including a nucleic-acid-containing complex is characterized in that two single strand nucleic acid polymers which can at least partly form double strands are separately mixed, in a single strand form, with a cationic carrier or with source materials for the cationic carrier before the cationic carrier is formed. The resulting mixture is then dispersed in water during the production process of the nucleic-acid-containing complex.

    摘要翻译: 制备包含含核酸复合物的组合物的方法的特征在于,可以至少部分形成双链的两条单链核酸聚合物以单链形式与阳离子载体或源材料分开混合 在阳离子载体形成之前为阳离子载体。 然后将所得混合物在含核酸复合物的制备过程中分散在水中。